Report Detail
Global (United States, European Union and China) Short Bowel Syndrome Market Research Report 2019-2025
- RnM3674648 |
- 16 August, 2019 |
- Global |
- 117 Pages |
- QYResearch |
- Pharma & Healthcare
Short bowel syndrome (SBS) is an intestinal disorder associated with malabsorption due to the lack of functional intestine. SBS can be congenital or an acquired condition which can be observed in patients in whom nearly half of the small intestine has been removed due to underlying disease condition.
The medications prescribed for the treatment of SBS include teduglutide and growth hormones (aid in intestinal absorption), proton pump inhibitors (used to treat gastric acid secretions), and anti-diarrheal (to treat the primary symptom of SBS, i.e., diarrhea). As the patients with SBS have lost major part of the intestine, retaining nutrients in such patients through oral nutrition becomes difficult. Hence parenteral nutrition is the preferred mode of treatment in these patients.
In 2019, the market size of Short Bowel Syndrome is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Short Bowel Syndrome.
This report studies the global market size of Short Bowel Syndrome, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Short Bowel Syndrome sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Shire
Merck
Emmaus Life Sciences
Nutrinia
GlyPharma Therapeutics
OxThera
Ardelyx
Sancilio & Company
Naia Pharmaceuticals
Zealand Pharma
Market Segment by Product Type
GLP-2
Growth Hormone
Glutamine
Others
Market Segment by Application
Hospitals
Clinics
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Short Bowel Syndrome status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Short Bowel Syndrome manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Short Bowel Syndrome are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global Short Bowel Syndrome Market Size Growth Rate by Type (2019-2025)
- 1.3.2 GLP-2
- 1.3.3 Growth Hormone
- 1.3.4 Glutamine
- 1.3.5 Others
- 1.4 Market Segment by Application
- 1.4.1 Global Short Bowel Syndrome Market Share by Application (2019-2025)
- 1.4.2 Hospitals
- 1.4.3 Clinics
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Global Short Bowel Syndrome Market Size
- 2.1.1 Global Short Bowel Syndrome Revenue 2014-2025
- 2.1.2 Global Short Bowel Syndrome Sales 2014-2025
- 2.2 Short Bowel Syndrome Growth Rate by Regions
- 2.2.1 Global Short Bowel Syndrome Sales by Regions 2014-2019
- 2.2.2 Global Short Bowel Syndrome Revenue by Regions 2014-2019
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Short Bowel Syndrome Sales by Manufacturers
- 3.1.1 Short Bowel Syndrome Sales by Manufacturers 2014-2019
- 3.1.2 Short Bowel Syndrome Sales Market Share by Manufacturers 2014-2019
- 3.2 Revenue by Manufacturers
- 3.2.1 Short Bowel Syndrome Revenue by Manufacturers (2014-2019)
- 3.2.2 Short Bowel Syndrome Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Short Bowel Syndrome Market Concentration Ratio (CR5 and HHI)
- 3.3 Short Bowel Syndrome Price by Manufacturers
- 3.4 Key Manufacturers Short Bowel Syndrome Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into Short Bowel Syndrome Market
- 3.6 Key Manufacturers Short Bowel Syndrome Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Sales and Revenue for Each Type
- 4.1.1 GLP-2 Sales and Revenue (2014-2019)
- 4.1.2 Growth Hormone Sales and Revenue (2014-2019)
- 4.1.3 Glutamine Sales and Revenue (2014-2019)
- 4.1.4 Others Sales and Revenue (2014-2019)
- 4.2 Global Short Bowel Syndrome Sales Market Share by Type
- 4.3 Global Short Bowel Syndrome Revenue Market Share by Type
- 4.4 Short Bowel Syndrome Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global Short Bowel Syndrome Sales by Application
6 United States
- 6.1 United States Short Bowel Syndrome Breakdown Data by Company
- 6.2 United States Short Bowel Syndrome Breakdown Data by Type
- 6.3 United States Short Bowel Syndrome Breakdown Data by Application
7 European Union
- 7.1 European Union Short Bowel Syndrome Breakdown Data by Company
- 7.2 European Union Short Bowel Syndrome Breakdown Data by Type
- 7.3 European Union Short Bowel Syndrome Breakdown Data by Application
8 China
- 8.1 China Short Bowel Syndrome Breakdown Data by Company
- 8.2 China Short Bowel Syndrome Breakdown Data by Type
- 8.3 China Short Bowel Syndrome Breakdown Data by Application
9 Rest of World
- 9.1 Rest of World Short Bowel Syndrome Breakdown Data by Company
- 9.2 Rest of World Short Bowel Syndrome Breakdown Data by Type
- 9.3 Rest of World Short Bowel Syndrome Breakdown Data by Application
- 9.4 Rest of World Short Bowel Syndrome Breakdown Data by Countries
- 9.4.1 Rest of World Short Bowel Syndrome Sales by Countries
- 9.4.2 Rest of World Short Bowel Syndrome Revenue by Countries
- 9.4.3 Japan
- 9.4.4 Korea
- 9.4.5 India
- 9.4.6 Southeast Asia
10 Company Profiles
- 10.1 Shire
- 10.1.1 Shire Company Details
- 10.1.2 Company Description and Business Overview
- 10.1.3 Sales, Revenue and Market Share of Short Bowel Syndrome
- 10.1.4 Short Bowel Syndrome Product Introduction
- 10.1.5 Shire Recent Development
- 10.2 Merck
- 10.2.1 Merck Company Details
- 10.2.2 Company Description and Business Overview
- 10.2.3 Sales, Revenue and Market Share of Short Bowel Syndrome
- 10.2.4 Short Bowel Syndrome Product Introduction
- 10.2.5 Merck Recent Development
- 10.3 Emmaus Life Sciences
- 10.3.1 Emmaus Life Sciences Company Details
- 10.3.2 Company Description and Business Overview
- 10.3.3 Sales, Revenue and Market Share of Short Bowel Syndrome
- 10.3.4 Short Bowel Syndrome Product Introduction
- 10.3.5 Emmaus Life Sciences Recent Development
- 10.4 Nutrinia
- 10.4.1 Nutrinia Company Details
- 10.4.2 Company Description and Business Overview
- 10.4.3 Sales, Revenue and Market Share of Short Bowel Syndrome
- 10.4.4 Short Bowel Syndrome Product Introduction
- 10.4.5 Nutrinia Recent Development
- 10.5 GlyPharma Therapeutics
- 10.5.1 GlyPharma Therapeutics Company Details
- 10.5.2 Company Description and Business Overview
- 10.5.3 Sales, Revenue and Market Share of Short Bowel Syndrome
- 10.5.4 Short Bowel Syndrome Product Introduction
- 10.5.5 GlyPharma Therapeutics Recent Development
- 10.6 OxThera
- 10.6.1 OxThera Company Details
- 10.6.2 Company Description and Business Overview
- 10.6.3 Sales, Revenue and Market Share of Short Bowel Syndrome
- 10.6.4 Short Bowel Syndrome Product Introduction
- 10.6.5 OxThera Recent Development
- 10.7 Ardelyx
- 10.7.1 Ardelyx Company Details
- 10.7.2 Company Description and Business Overview
- 10.7.3 Sales, Revenue and Market Share of Short Bowel Syndrome
- 10.7.4 Short Bowel Syndrome Product Introduction
- 10.7.5 Ardelyx Recent Development
- 10.8 Sancilio & Company
- 10.8.1 Sancilio & Company Company Details
- 10.8.2 Company Description and Business Overview
- 10.8.3 Sales, Revenue and Market Share of Short Bowel Syndrome
- 10.8.4 Short Bowel Syndrome Product Introduction
- 10.8.5 Sancilio & Company Recent Development
- 10.9 Naia Pharmaceuticals
- 10.9.1 Naia Pharmaceuticals Company Details
- 10.9.2 Company Description and Business Overview
- 10.9.3 Sales, Revenue and Market Share of Short Bowel Syndrome
- 10.9.4 Short Bowel Syndrome Product Introduction
- 10.9.5 Naia Pharmaceuticals Recent Development
- 10.10 Zealand Pharma
- 10.10.1 Zealand Pharma Company Details
- 10.10.2 Company Description and Business Overview
- 10.10.3 Sales, Revenue and Market Share of Short Bowel Syndrome
- 10.10.4 Short Bowel Syndrome Product Introduction
- 10.10.5 Zealand Pharma Recent Development
11 Value Chain and Sales Channels Analysis
- 11.1 Value Chain Analysis
- 11.2 Sales Channels Analysis
- 11.2.1 Short Bowel Syndrome Sales Channels
- 11.2.2 Short Bowel Syndrome Distributors
- 11.3 Short Bowel Syndrome Customers
12 Market Forecast
- 12.1 Global Short Bowel Syndrome Sales and Revenue Forecast 2019-2025
- 12.2 Global Short Bowel Syndrome Sales Forecast by Type
- 12.3 Global Short Bowel Syndrome Sales Forecast by Application
- 12.4 Short Bowel Syndrome Forecast by Regions
- 12.4.1 Global Short Bowel Syndrome Sales Forecast by Regions 2019-2025
- 12.4.2 Global Short Bowel Syndrome Revenue Forecast by Regions 2019-2025
- 12.5 United States Market Forecast
- 12.6 European Union Market Forecast
- 12.7 China Market Forecast
- 12.8 Rest of World
- 12.8.1 Japan
- 12.8.2 Korea
- 12.8.3 India
13 Research Findings and Conclusion
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.1.1 Research Programs/Design
- 14.1.1.2 Market Size Estimation
- 14.1.1.3 Market Breakdown and Data Triangulation
- 14.1.2 Data Source
- 14.1.2.1 Secondary Sources
- 14.1.2.2 Primary Sources
- 14.1.1 Methodology/Research Approach
- 14.2 Author Details
Summary:
Get latest Market Research Reports on Short Bowel Syndrome. Industry analysis & Market Report on Short Bowel Syndrome is a syndicated market report, published as Global (United States, European Union and China) Short Bowel Syndrome Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Short Bowel Syndrome market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
